Personal information

Other IDs

Scopus Author ID: 6603954612

Activities

Collapse all

Employment (1)

Università degli Studi del Piemonte Orientale: Vercelli, Novara, Alessandria, Piemonte, IT

Associate Professor (Department of Traslational Medicine)
Employment
Source: Self-asserted source
Marco Ladetto

Works (50 of 134)

Items per page:
Page 1 of 3

Corrigendum: ESMO consensus conference on malignant lymphoma: General perspectives and recommendations for prognostic tools in mature B-cell lymphomas and chronic lymphocytic leukaemia. [Ann Oncol 27, (2016) (2149-2160)] DOI: 10.1093/annonc/mdw419

Annals of Oncology
2018 | Journal article
DOI: 10.1093/annonc/mdx061
EID:

2-s2.0-85042563861
Contributors: Ladetto, M.; Buske, C.; Hutchings, M.; Dreyling, M.; Gaidano, G.; Le Gouill, S.; Luminari, S.; Pott, C.; Zamò, A.; Zucca, E.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Ficoll-hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis

International Journal of Laboratory Hematology
2018 | Journal article
DOI: 10.1111/ijlh.12766
EID:

2-s2.0-85037660773
Contributors: Genuardi, E.; Barbero, D.; Dogliotti, I.; Mantoan, B.; Drandi, D.; Gambella, M.; Zaccaria, G.M.; Monitillo, L.; Della Starza, I.; Cavalli, M. et al.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Minimal Residual Disease in Multiple Myeloma

Hematologic Malignancies
2018 | Book
DOI: 10.1007/978-3-319-25586-6_6
EID:

2-s2.0-85042256283
Contributors: Puig, N.; Palladino, C.; Paiva, B.; Ladetto, M.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma

Biology of Blood and Marrow Transplantation
2018 | Journal article
DOI: 10.1016/j.bbmt.2018.01.035
EID:

2-s2.0-85042945262
Contributors: Garderet, L.; Iacobelli, S.; Koster, L.; Goldschmidt, H.; Johansson, J.-E.; Bourhis, J.H.; Krejci, M.; Leleu, X.; Potter, M.; Blaise, D. et al.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi

Leukemia and Lymphoma
2018 | Journal article
DOI: 10.1080/10428194.2018.1452208
EID:

2-s2.0-85044938873
Contributors: Zaja, F.; Salvi, F.; Rossi, M.; Sabattini, E.; Evangelista, A.; Ciccone, G.; Angelucci, E.; Gaidano, G.; Zanni, M.; Ladetto, M. et al.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Corrigendum: Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [Ann Oncol, 27(Suppl 5), (2016), (v83-v90)] doi: 10.1093/annonc/mdw400

Annals of Oncology
2017 | Journal article
DOI: 10.1093/annonc/mdx020
EID:

2-s2.0-85042059455
Contributors: Dreyling, M.; Ghielmini, M.; Rule, S.; Salles, G.; Vitolo, U.; Ladetto, M.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Data quality improvement of a multicenter clinical trial dataset

Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS
2017 | Conference paper
DOI: 10.1109/EMBC.2017.8037043
EID:

2-s2.0-85032210164
Contributors: Zaccaria, G.M.; Rosati, S.; Castagneri, C.; Ferrero, S.; Ladetto, M.; Boccadoro, M.; Balestra, G.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

HashClone: A new tool to quantify the minimal residual disease in B-cell lymphoma from deep sequencing data

BMC Bioinformatics
2017 | Journal article
DOI: 10.1186/s12859-017-1923-2
EID:

2-s2.0-85035222304
Contributors: Beccuti, M.; Genuardi, E.; Romano, G.; Monitillo, L.; Barbero, D.; Boccadoro, M.; Ladetto, M.; Calogero, R.; Ferrero, S.; Cordero, F.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Infections and Follicular Lymphoma: Is there a Link?

Mediterranean Journal of Hematology and Infectious Diseases
2017 | Journal article
DOI: 10.4084/MJHID.2017.035
EID:

2-s2.0-85018371432
Contributors: Zallio, F.; Limberti, G.; Ladetto, M.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Khorana score and histotype predicts incidence of early venous thromboembolism in Non-Hodgkin lymphomas: A Pooled-Data analysis of 12 clinical trials of fondazione italiana linfomi (FIL)

Thrombosis and Haemostasis
2017 | Journal article
DOI: 10.1160/TH16-11-0895
EID:

2-s2.0-85026822217
Contributors: Santi, R.M.; Ceccarelli, M.; Bernocco, E.; Monagheddu, C.; Evangelista, A.; Valeri, F.; Monaco, F.; Vitolo, U.; Cortelazzo, S.; Cabras, M.G. et al.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of Oncology
2017 | Journal article
DOI: 10.1093/annonc/mdx223
EID:

2-s2.0-85029682231
Contributors: Dreyling, M.; Campo, E.; Hermine, O.; Jerkeman, M.; Le Gouill, S.; Rule, S.; Shpilberg, O.; Walewski, J.; Ladetto, M.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: Evidences from long term follow-up

British Journal of Haematology
2017 | Journal article
DOI: 10.1111/bjh.14681
EID:

2-s2.0-85017135010
Contributors: Ghione, P.; Genuardi, E.; Rossi, D.; Drandi, D.; Mantoan, B.; Barbero, D.; Bernocco, E.; Monitillo, L.; Cerri, M.; Ruggeri, M. et al.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi

The Lancet Haematology
2017 | Journal article
DOI: 10.1016/S2352-3026(16)30185-5
EID:

2-s2.0-85007331818
Contributors: Visco, C.; Chiappella, A.; Nassi, L.; Patti, C.; Ferrero, S.; Barbero, D.; Evangelista, A.; Spina, M.; Molinari, A.; Rigacci, L. et al.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: A phase II clinical trial of the fondazione italiana linfomi

Haematologica
2017 | Journal article
DOI: 10.3324/haematol.2016.154211
EID:

2-s2.0-85019004698
Contributors: Zaja, F.; Ferrero, S.; Stelitano, C.; Ferrari, A.; Salvi, F.; Arcari, A.; Musuraca, G.; Botto, B.; Spina, M.; Cellini, C. et al.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Thirty-month complete response as a surrogate end point in first-line follicular lymphoma therapy: An individual patient-level analysis of multiple randomized trials

Journal of Clinical Oncology
2017 | Journal article
DOI: 10.1200/JCO.2016.70.8651
EID:

2-s2.0-85012926967
Contributors: Shi, Q.; Flowers, C.R.; Hiddemann, W.; Marcus, R.; Herold, M.; Hagenbeek, A.; Kimby, E.; Hochster, H.; Vitolo, U.; Peterson, B.A. et al.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

A Single-Center Pilot Prospective Study of Topical Application of Platelet-Derived Eye Drops for Patients with Ocular Chronic Graft-versus-Host Disease

Biology of Blood and Marrow Transplantation
2016 | Journal article
DOI: 10.1016/j.bbmt.2016.05.023
EID:

2-s2.0-84979583948
Contributors: Zallio, F.; Mazzucco, L.; Monaco, F.; Astori, M.R.; Passera, R.; Drago, G.; Tamiazzo, S.; Rapetti, M.; Dolcino, D.; Guaschino, R. et al.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Addition of rituximab to involved-field radiation therapy prolongs progression-free survival in stage I-II follicular lymphoma: Results of a multicenter study

International Journal of Radiation Oncology Biology Physics
2016 | Journal article
DOI: 10.1016/j.ijrobp.2015.12.019
EID:

2-s2.0-84959573889
Contributors: Ruella, M.; Filippi, A.R.; Bruna, R.; Di Russo, A.; Magni, M.; Caracciolo, D.; Passera, R.; Matteucci, P.; Di Nicola, M.; Corradini, P. et al.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Combinatorial targeting of nuclear export and translation of RNA inhibits aggressive B-cell lymphomas

Blood
2016 | Journal article
DOI: 10.1182/blood-2015-05-645069
EID:

2-s2.0-84959372285
Contributors: Culjkovic-Kraljacic, B.; Fernando, T.M.; Marullo, R.; Calvo-Vidal, N.; Verma, A.; Yang, S.; O, F.T.; Gaudiano, M.; Zahreddine, H.; Goldstein, R.L. et al.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Comparison of different DNA extraction methods from peripheral blood cells: Advice from the Fondazione Italiana Linfomi Minimal Residual Disease Network

Leukemia and Lymphoma
2016 | Journal article
DOI: 10.3109/10428194.2014.914199
EID:

2-s2.0-84954489266
Contributors: Mannu, C.; Gazzola, A.; Ciabatti, E.; Fuligni, F.; Cavalli, M.; Della Starza, I.; Genuardi, E.; Mantoan, B.; Monitillo, L.; Del Giudice, I. et al.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

ESMO consensus conference on malignant lymphoma: general perspectives and recommendations for prognostic tools in mature B-cell lymphomas and chronic lymphocytic leukaemia

Annals of oncology : official journal of the European Society for Medical Oncology
2016 | Journal article
DOI: 10.1093/annonc/mdw419
EID:

2-s2.0-85039042948
Contributors: Ladetto, M.; Buske, C.; Hutchings, M.; Dreyling, M.; Gaidano, G.; Le Gouill, S.; Luminari, S.; Pott, C.; Zamò, A.; Zucca, E.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Extranodal diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up

Annals of Oncology
2016 | Journal article
DOI: 10.1093/annonc/mdw175
EID:

2-s2.0-84995739806
Contributors: Vitolo, U.; Seymour, J.F.; Martelli, M.; Illerhaus, G.; Illidge, T.; Zucca, E.; Campo, E.; Ladetto, M.; on behalf of the ESMO Guidelines Committee
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Newly diagnosed and relapsed follicular lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up

Annals of Oncology
2016 | Journal article
DOI: 10.1093/annonc/mdw400
EID:

2-s2.0-84995755292
Contributors: Dreyling, M.; Ghielmini, M.; Rule, S.; Salles, G.; Vitolo, U.; Ladetto, M.; on behalf of the ESMO Guidelines Committee
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Prospective molecular monitoring of minimal residual disease after non-myeloablative allografting in newly diagnosed multiple myeloma

Leukemia
2016 | Journal article
DOI: 10.1038/leu.2015.269
EID:

2-s2.0-84945552220
Contributors: Ladetto, M.; Ferrero, S.; Drandi, D.; Festuccia, M.; Patriarca, F.; Mordini, N.; Cena, S.; Benedetto, R.; Guarona, G.; Ferrando, F. et al.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Randomized trial comparing R-CHOP versus high-dose sequential chemotherapy in high-risk patients with diffuse large B-cell lymphomas

Journal of Clinical Oncology
2016 | Journal article
DOI: 10.1200/JCO.2016.67.2980
EID:

2-s2.0-84995810071
Contributors: Cortelazzo, S.; Tarella, C.; Gianni, A.M.; Ladetto, M.; Barbui, A.M.; Rossi, A.; Gritti, G.; Corradini, P.; Di Nicola, M.; Patti, C. et al.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting)

Leukemia and Lymphoma
2016 | Journal article
DOI: 10.3109/10428194.2015.1131278
EID:

2-s2.0-84953271380
Contributors: Bruno, B.; Auner, H.W.; Gahrton, G.; Garderet, L.; Festuccia, M.; Ladetto, M.; Lemoli, R.M.; Massaia, M.; Morris, C.; Palumbo, A. et al.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Autologous stem cell transplantation with in vivo purged progenitor cells shows long-term efficacy in relapsed/refractory follicular lymphoma

American Journal of Hematology
2015 | Journal article
DOI: 10.1002/ajh.23919
EID:

2-s2.0-84923026608
Contributors: Arcaini, L.; Morello, L.; Tucci, A.; Rusconi, C.; Ladetto, M.; Rattotti, S.; Bonfichi, M.; Bottelli, C.; Gabutti, C.; Bernasconi, P. et al.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of Oncology
2015 | Journal article
DOI: 10.1093/annonc/mdv304
EID:

2-s2.0-84941642996
Contributors: Tilly, H.; Gomes da Silva, M.; Vitolo, U.; Jack, A.; Meignan, M.; Lopez-Guillermo, A.; Walewski, J.; André, M.; Johnson, P.W.; Pfreundschuh, M. et al.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Epigenomic evolution in diffuse large B-cell lymphomas

Nature Communications
2015 | Journal article
DOI: 10.1038/ncomms7921
EID:

2-s2.0-84928473373
Contributors: Pan, H.; Jiang, Y.; Boi, M.; Tabbò, F.; Redmond, D.; Nie, K.; Ladetto, M.; Chiappella, A.; Cerchietti, L.; Shaknovich, R. et al.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Long-term results of the GIMEMA VEL-03-096 trial in MM patients receiving VTD consolidation after ASCT: MRD kinetics' impact on survival

Leukemia
2015 | Journal article
DOI: 10.1038/leu.2014.219
EID:

2-s2.0-84924536232
Contributors: Ferrero, S.; Ladetto, M.; Drandi, D.; Cavallo, F.; Genuardi, E.; Urbano, M.; Caltagirone, S.; Grasso, M.; Rossini, F.; Guglielmelli, T. et al.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma: A Comparison with Real-Time PCR

Journal of Molecular Diagnostics
2015 | Journal article
DOI: 10.1016/j.jmoldx.2015.05.007
EID:

2-s2.0-84943646655
Contributors: Drandi, D.; Kubiczkova-Besse, L.; Ferrero, S.; Dani, N.; Passera, R.; Mantoan, B.; Gambella, M.; Monitillo, L.; Saraci, E.; Ghione, P. et al.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of Oncology
2015 | Journal article
DOI: 10.1093/annonc/mdv201
EID:

2-s2.0-84941616851
Contributors: d'Amore, F.; Gaulard, P.; Trümper, L.; Corradini, P.; Kim, W.-S.; Specht, L.; Bjerregaard Pedersen, M.; Ladetto, M.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells

Oncotarget
2015 | Journal article
DOI: 10.18632/oncotarget.4006
EID:

2-s2.0-84945156951
Contributors: Rigoni, M.; Riganti, C.; Vitale, C.; Griggio, V.; Campia, I.; Robino, M.; Foglietta, M.; Castella, B.; Sciancalepore, P.; Buondonno, I. et al.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Using PET-CT in the restaging of primitive mediastinal B-cell lymphoma (PMBCL) after chemotherapy: Which criteria should we use?

Quarterly Journal of Nuclear Medicine and Molecular Imaging
2015 | Journal article
EID:

2-s2.0-84944887820
Contributors: Giunta, F.; Zotta, M.; Menga, M.; Balma, M.; Bellò, M.; Passera, R.; Filippi, A.R.; Chiappella, A.; Ladetto, M.; Ricardi, U. et al.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: A study of the Fondazione Italiana Linfomi

Annals of Oncology
2014 | Journal article
DOI: 10.1093/annonc/mdu166
EID:

2-s2.0-84903701048
Contributors: Arcaini, L.; Vallisa, D.; Rattotti, S.; Ferretti, V.V.; Ferreri, A.J.M.; Bernuzzi, P.; Merli, M.; Varettoni, M.; Chiappella, A.; Ambrosetti, A. et al.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Comparison of two real-time quantitative polymerase chain reaction strategies for minimal residual disease evaluation in lymphoproliferative disorders: Correlation between immunoglobulin gene mutation load and real-time quantitative polymerase chain reaction performance

Hematological Oncology
2014 | Journal article
DOI: 10.1002/hon.2095
EID:

2-s2.0-84921712051
Contributors: Della Starza, I.; Cavalli, M.; Del Giudice, I.; Barbero, D.; Mantoan, B.; Genuardi, E.; Urbano, M.; Mannu, C.; Gazzola, A.; Ciabatti, E. et al.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomib

Haematologica
2014 | Journal article
DOI: 10.3324/haematol.2013.090142
EID:

2-s2.0-84896736185
Contributors: Gambella, M.; Rocci, A.; Passera, R.; Gay, F.; Omedè, P.; Crippa, C.; Corradini, P.; Romano, A.; Rossi, D.; Ladetto, M. et al.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Hodgkin's lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up

Annals of Oncology
2014 | Journal article
DOI: 10.1093/annonc/mdu181
EID:

2-s2.0-84911479245
Contributors: Eichenauer, D.A.; Engert, A.; André, M.; Federico, M.; Illidge, T.; Hutchings, M.; Ladetto, M.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Inter- and intratumoral heterogeneity of BCL2 correlates with IgH expression and prognosis in follicular lymphoma

Blood Cancer Journal
2014 | Journal article
DOI: 10.1038/bcj.2014.67
EID:

2-s2.0-84921489660
Contributors: Barreca, A.; Martinengo, C.; Annaratone, L.; Righi, L.; Chiappella, A.; Ladetto, M.; Demurtas, A.; Chiusa, L.; Stacchini, A.; Crosetto, N. et al.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: Results of the REAL07 open-label, multicentre, phase 2 trial

The Lancet Oncology
2014 | Journal article
DOI: 10.1016/S1470-2045(14)70191-3
EID:

2-s2.0-84901391325
Contributors: Vitolo, U.; Chiappella, A.; Franceschetti, S.; Carella, A.M.; Baldi, I.; Inghirami, G.; Spina, M.; Pavone, V.; Ladetto, M.; Liberati, A.M. et al.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

MET dysregulation is a hallmark of aggressive disease in multiple myeloma patients

British Journal of Haematology
2014 | Journal article
DOI: 10.1111/bjh.12719
EID:

2-s2.0-84896701281
Contributors: Rocci, A.; Gambella, M.; Aschero, S.; Baldi, I.; Trusolino, L.; Cavallo, F.; Gay, F.; Larocca, A.; Magarotto, V.; Omedè, P. et al.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: The FIL FOLL05 trial

Clinical Cancer Research
2014 | Journal article
DOI: 10.1158/1078-0432.CCR-14-0407
EID:

2-s2.0-84919687996
Contributors: Galimberti, S.; Luminari, S.; Ciabatti, E.; Grassi, S.; Guerrini, F.; Dondi, A.; Marcheselli, L.; Ladetto, M.; Piccaluga, P.P.; Gazzola, A. et al.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Newly diagnosed and relapsed follicular lymphoma: Esmo clinical practice guidelines for diagnosis, treatment and follow-up

Annals of Oncology
2014 | Journal article
DOI: 10.1093/annonc/mdu200
EID:

2-s2.0-84911483017
Contributors: Dreyling, M.; Ghielmini, M.; Marcus, R.; Salles, G.; Vitolo, U.; Ladetto, M.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Newly diagnosed and relapsed mantle cell lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up

Annals of Oncology
2014 | Journal article
DOI: 10.1093/annonc/mdu264
EID:

2-s2.0-84911469440
Contributors: Dreyling, M.; Geisler, C.; Hermine, O.; Kluin-Nelemans, H.C.; Le Gouill, S.; Rule, S.; Shpilberg, O.; Walewski, J.; Ladetto, M.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders

Leukemia
2014 | Journal article
DOI: 10.1038/leu.2013.375
EID:

2-s2.0-84902075123
Contributors: Ladetto, M.; Brüggemann, M.; Monitillo, L.; Ferrero, S.; Pepin, F.; Drandi, D.; Barbero, D.; Palumbo, A.; Passera, R.; Boccadoro, M. et al.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Clinical implications and prognostic role of minimal residual disease detection in follicular lymphoma

Therapeutic Advances in Hematology
2013 | Journal article
DOI: 10.1177/2040620713480522
EID:

2-s2.0-84993763138
Contributors: Lobetti Bodoni, C.; Mantoan, B.; Monitillo, L.; Genuardi, E.; Drandi, D.; Barbero, D.; Bernocco, E.; Boccadoro, M.; Ladetto, M.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Esmo consensus conferences: Guidelines on malignant lymphoma. Part 2: Marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma

Annals of Oncology
2013 | Journal article
DOI: 10.1093/annonc/mds643
EID:

2-s2.0-84875594520
Contributors: Dreyling, M.; Thieblemont, C.; Gallamini, A.; Arcaini, L.; Campo, E.; Hermine, O.; Kluin-Nelemans, J.C.; Ladetto, M.; Le Gouill, S.; Iannitto, E. et al.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Gastric marginal zone lymphoma of MALT type: ESMO clinical practice guidelines for diagnosis, treatment and follow-up

Annals of Oncology
2013 | Journal article
DOI: 10.1093/annonc/mdt343
EID:

2-s2.0-84885359565
Contributors: Zucca, E.; Copie-Bergman, C.; Ricardi, U.; Thieblemont, C.; Raderer, M.; Ladetto, M.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Large genomic aberrations detected by SNP array are independent prognosticators of a shorter time to first treatment in chronic lymphocytic leukemia patients with normal FISH

Annals of Oncology
2013 | Journal article
DOI: 10.1093/annonc/mds646
EID:

2-s2.0-84877147722
Contributors: Mian, M.; Rinaldi, A.; Mensah, A.A.; Rossi, D.; Ladetto, M.; Forconi, F.; Marasca, R.; Uhr, M.; Stussi, G.; Kwee, I. et al.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: A phase I study by the Fondazione Italiana Linfomi

Haematologica
2013 | Journal article
DOI: 10.3324/haematol.2013.085134
EID:

2-s2.0-84887011781
Contributors: Chiappella, A.; Tucci, A.; Castellino, A.; Pavone, V.; Baldi, I.; Carella, A.M.; Orsucci, L.; Zanni, M.; Salvi, F.; Liberati, A.M. et al.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier

MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia

Leukemia and Lymphoma
2013 | Journal article
DOI: 10.3109/10428194.2012.723706
EID:

2-s2.0-84876275925
Contributors: De Paoli, L.; Cerri, M.; Monti, S.; Rasi, S.; Spina, V.; Bruscaggin, A.; Greco, M.; Ciardullo, C.; Famà, R.; Cresta, S. et al.
Source: Self-asserted source
Marco Ladetto via Scopus - Elsevier
Items per page:
Page 1 of 3
How many people are using ORCID?